Search results

A leading developer of novel cancer therapeutics was experiencing persistent manufacturing process issues. Our engineers were able to diagnose and solve two problems.

See how Altasciences supported a sponsor’s 505(b)(2) submission with three pivotal studies, driving simulation, bioavailability, and dose-escalation, to deliver critical data.

Gretchen Green recaps the ARVO 2025 annual meeting, highlighting AI in ophthalmology, gene therapy, and preclinical advances in ocular safety and drug delivery.

Early-phase drug development is a complex process. Discover how Altasciences, as an integrated CRO/CDMO, alleviates the challenges and reduces risks.

Can the drug development industry change for the better? We dive into the obstacles and inefficiencies of the traditional outsourcing paradigm, and discuss how Altasciences offers an alternative to help sponsors safely accelerate their R&D.

Delve into the core of pharmacokinetics, pharmacodynamics, and toxicokinetics with Altasciences. Uncover the intricate relations that drive drug discovery and development with an engaging exploration.